Lidocaine patch 5%.
D000279:Administration, Cutaneous; D000779:Anesthetics, Local / Q000494:pharmacology / Q000627:therapeutic use*; D003929:Diabetic Neuropathies / Q000150:complications; D004334:Drug Administration Schedule; D015658:HIV Infections / Q000150:complications; D006562:Herpes Zoster / Q000150:complications; D006801:Humans; D008012:Lidocaine / Q000494:pharmacology / Q000627:therapeutic use*; D009437:Neuralgia / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D010146:Pain / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D010147:Pain Measurement; D018579:Patient Selection; D012869:Skin Absorption; D016896:Treatment Outcome
D000779:Anesthetics, Local; D008012:Lidocaine